Anna Lucsok
Net Worth

Last updated:

What is Anna Lucsok net worth?

The estimated net worth of Ms. Anna Lucsok is at least $855,418 as of 7 Aug 2024. She owns shares worth $26,998 as insider, has earned $315,750 from insider trading and has received compensation worth at least $512,670 in Zynex, Inc..

What is the salary of Anna Lucsok?

Ms. Anna Lucsok salary is $170,890 per year as Chief Operating Officer in Zynex, Inc..

How old is Anna Lucsok?

Ms. Anna Lucsok is 39 years old, born in 1986.

What stocks does Anna Lucsok currently own?

As insider, Ms. Anna Lucsok owns shares in one company:

Company Title Shares Price per share Total value
Zynex, Inc. (ZYXI) Chief Operating Officer 16,980 $1.59 $26,998

What does Zynex, Inc. do?

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Anna Lucsok insider trading

Zynex, Inc.

Ms. Anna Lucsok has made 4 insider trades between 2022-2024, according to the Form 4 filled with the SEC. Most recently she sold 8,083 units of ZYXI stock worth $64,906 on 7 Aug 2024.

The largest trade she's ever made was exercising 16,792 units of ZYXI stock on 6 Aug 2024. As of 7 Aug 2024 she still owns at least 16,980 units of ZYXI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 8,083 $8.03 $64,906
Sale
Common Stock 16,792 $8.01 $134,504
Sale
Common Stock 12,000 $8.41 $100,920
Sale
Common Stock 1,103 $13.98 $15,420

Zynex key executives

Zynex, Inc. executives and other stock owners filed with the SEC: